Placebo-controlled Study to Determine the Safety and Tolerability of Subcutaneous Doses of Sevuparin
Clinical trial NCT03853421 · COMPLETED
Trial details
- NCT number
- NCT03853421
- Sponsor
- Modus Therapeutics AB
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-06
- Primary completion
- 2019-05-06
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.